Sign up USA
Proactive Investors - Run By Investors For Investors

Ultrasis to help East Midlands PCTs beat mild to moderate depression

Ultrasis plc (AIM:ULT) provider of interactive health care services announced that seven Primary Care Trusts (PCTs) in the East Midlands have contracted to provide ‘Beating the Blues’ (a computerised form of Cognitive Behavioural Therapy) to all their patients with mild to moderate depression.The agreement is a significant breakthrough for Ultrasis, the two-year agreement has an...
no_picture_pai.jpg
Ultrasis plc (AIM:ULT) provider of interactive health care services announced that seven Primary Care Trusts (PCTs) in the East Midlands have contracted to provide ‘Beating the Blues’ (a computerised form of Cognitive Behavioural Therapy) to all their patients with mild to moderate depression.

The agreement is a significant breakthrough for Ultrasis, the two-year agreement has an initial value of more than £450,000. It will enable the PCTs involved to be at least 25% compliant with the implementation requirements of The National Institute for Health and Clinical Excellence (NICE).

Nigel Brabbins, Chief Executive of Ultrasis, said:

"In March 2007 Patricia Hewitt, then Health Secretary, promised to make ‘Beating the Blues’ available nationally to any patient who needs it. We are actively campaigning to encourage the recently appointed Secretary of State for Health, Alan Johnson, to implement the NICE guidance."

Shares in Ultrasis rose 21% to 1.08p on the news.


Register here to be notified of future ULT Company articles
View full ULT profile

Ultrasis Timeline

Related Articles

FatCity.jpg
January 13 2016
If everyone could be as active as the York-based outfit there would not be such a pressing demand for its products.
Benjamin Franklin wearing a medical mask
March 24 2016
Constellation has identified a significant market opportunity in healthcare billing management.
AZN2.jpg
March 31 2016
Amryt Pharmaceuticals will join the London market in a deal that values it at £29.6mln. A share placing, meanwhile, will bring in £10mln to be used to develop the company’s lead treatment for a rare skin disorder.
Copyright © Proactiveinvestors.com, 2016. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC